Clincosm LogoSign in Get a demo

dermatomyositis

Showing 1 - 25 of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning

Recruiting
  • Idiopathic Inflammatory Myopathy
  • +3 more
  • CAB-201 following preconditioning with fludarabine and cyclophosphamide
  • Orange, California
    University of California Irvine
Nov 30, 2023

Lymphocyte Subsets of Peripheral Blood in Nonmyopathic

Recruiting
  • Dermatomyositis
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 19, 2023

    SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

    Recruiting
    • SLE (Systemic Lupus)
    • +4 more
    • CD19 targeted CAR-T cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Sep 25, 2023

    Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis

    Recruiting
    • Dermatomyositis
    • +2 more
      • Zhejiang, Hangzhou, China
        The Third People's Hospital of Hangzhou
      Aug 21, 2023

      Severity in Juvenile and Adult-onset Dermatomyositis

      Not yet recruiting
      • Dermatomyositis
      • evaluation of clinical severity
      • (no location specified)
      Aug 16, 2023

      Dermatomyositis, Polymyositis, Idiopathic Inflammatory Myopathies Trial (Froniglutide, Placebo)

      Not yet recruiting
      • Dermatomyositis
      • +2 more
      • (no location specified)
      Apr 16, 2023

      Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome Trial in Amsterdam (Immune Globulin Intravenous

      Recruiting
      • Inflammatory Myopathy, Idiopathic
      • +5 more
      • Immune Globulin Intravenous (Human)
      • Placebo
      • Amsterdam, North- Holland, Netherlands
        Department of Neurology, Amsterdam UMC, location AMC
      Apr 14, 2023

      Polymyositis, Dermatomyositis Trial in Gainesville (Umbilical Cord Lining Stem Cells)

      Active, not recruiting
      • Polymyositis
      • Dermatomyositis
      • Umbilical Cord Lining Stem Cells
      • Gainesville, Florida
        University of Florida
      Jan 31, 2023

      Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +15 more
      • Biospecimen Collection
      • Nivolumab
      • Birmingham, Alabama
      • +46 more
      Jan 31, 2023

      Dermatomyositis, Polymyositis Trial in Orlando (M5049 high dose, Placebo)

      Recruiting
      • Dermatomyositis
      • Polymyositis
      • M5049 high dose
      • Placebo
      • Orlando, Florida
        HMD Research LLC
      Jan 30, 2023

      Pathogenesis of Autoimmune/Connective Tissue Diseases

      Completed
      • Autoimmune/Connective Tissue Diseases
      • +3 more
        • Bethesda, Maryland
          National Institute of Environmental Health Sciences (NIEHS), 900
        Jan 25, 2023

        Dermatomyositis Trial in DeBary (GLPG3667, Placebo)

        Not yet recruiting
        • Dermatomyositis
        • DeBary, Florida
          Omega Research Consultants
        Jan 13, 2023

        Study and Treatment of Inflammatory Muscle Diseases

        Recruiting
        • Dermatomyositis
        • Polymyositis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 21, 2023

          Environmental Risk Factors for Myositis in Military Personnel

          Active, not recruiting
          • Dermatomyositis
          • +3 more
            • Bethesda, Maryland
            • +2 more
            Jan 21, 2023

            Adult and Juvenile Myositis

            Recruiting
            • Dermatomyositis
            • +2 more
              • Bethesda, Maryland
              • +1 more
              Jan 20, 2023

              Environmental Risk Factors for the Anti-synthetase Syndrome

              Recruiting
              • Myositis
              • +4 more
                • Bethesda, Maryland
                • +1 more
                Jan 7, 2023

                Plexin D1 as a Potential Biomarker inPM/DM

                Not yet recruiting
                • Polymyositis
                • Dermatomyositis
                • plexinD1
                • (no location specified)
                Nov 25, 2022

                Dermatomyositis, Idiopathic Inflammatory Myopathies Trial run by the National Institute of Environmental Health Sciences (NIEHS)

                Active, not recruiting
                • Dermatomyositis
                • Idiopathic Inflammatory Myopathies
                • Sodium Thiosulfate
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Nov 8, 2022

                Dermatomyositis Trial in Worldwide (human immunoglobulin G, Placebo)

                Recruiting
                • Dermatomyositis
                • human immunoglobulin G
                • Placebo
                • Glendale, Arizona
                • +75 more
                Nov 1, 2022

                Polymyositis, Dermatomyositis Trial in Worldwide (KZR-616, Placebo)

                Completed
                • Polymyositis
                • Dermatomyositis
                • Beverly Hills, California
                • +18 more
                Sep 30, 2022

                Dermatomyositis Trial in Strasbourg (exploration)

                Recruiting
                • Dermatomyositis
                • exploration
                • Strasbourg, France
                  Meyer
                Aug 18, 2022

                Dermatomyositis Trial in Worldwide (Ravulizumab, Placebo)

                Recruiting
                • Dermatomyositis
                • Orange, California
                • +35 more
                Aug 16, 2022

                Dermatomyositis Trial (Interleukin-2)

                Not yet recruiting
                • Dermatomyositis
                • (no location specified)
                Aug 8, 2022

                Polymyositis, Dermatomyositis, Autoimmune Necrotizing Myopathy Trial in Worldwide (Abatacept subcutaneous, Placebo)

                Terminated
                Has Results
                • Polymyositis
                • +4 more
                • Abatacept subcutaneous
                • Placebo
                • Phoenix, Arizona
                • +75 more
                Aug 4, 2022

                Dermatomyositis Trial in Nanchang (Lenalidomide)

                Not yet recruiting
                • Dermatomyositis
                • Nanchang, Jiangxi, China
                  Department of Rheumatology and Clinical Immunology, Jiangxi Prov
                Aug 3, 2022